JP2012507988A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012507988A5 JP2012507988A5 JP2011534924A JP2011534924A JP2012507988A5 JP 2012507988 A5 JP2012507988 A5 JP 2012507988A5 JP 2011534924 A JP2011534924 A JP 2011534924A JP 2011534924 A JP2011534924 A JP 2011534924A JP 2012507988 A5 JP2012507988 A5 JP 2012507988A5
- Authority
- JP
- Japan
- Prior art keywords
- oligonucleotide
- seq
- vegf antibody
- allele
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11166708P | 2008-11-05 | 2008-11-05 | |
| US61/111,667 | 2008-11-05 | ||
| US17485609P | 2009-05-01 | 2009-05-01 | |
| US61/174,856 | 2009-05-01 | ||
| PCT/US2009/063434 WO2010054110A2 (en) | 2008-11-05 | 2009-11-05 | Genetic polymorphisms in age-related macular degeneration |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012507988A JP2012507988A (ja) | 2012-04-05 |
| JP2012507988A5 true JP2012507988A5 (enExample) | 2014-09-18 |
| JP5701216B2 JP5701216B2 (ja) | 2015-04-15 |
Family
ID=41650496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011534924A Expired - Fee Related JP5701216B2 (ja) | 2008-11-05 | 2009-11-05 | 加齢黄斑変性における遺伝的多型 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20120003641A1 (enExample) |
| EP (2) | EP2540843B1 (enExample) |
| JP (1) | JP5701216B2 (enExample) |
| KR (1) | KR101719376B1 (enExample) |
| CN (2) | CN103333952B (enExample) |
| AU (1) | AU2009313475B2 (enExample) |
| CA (1) | CA2740242A1 (enExample) |
| DK (1) | DK2540843T3 (enExample) |
| ES (1) | ES2498274T3 (enExample) |
| IL (1) | IL211995A (enExample) |
| MX (1) | MX2011004763A (enExample) |
| PL (1) | PL2540843T3 (enExample) |
| SI (1) | SI2540843T1 (enExample) |
| WO (1) | WO2010054110A2 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CR20170001A (es) | 2008-04-28 | 2017-08-10 | Genentech Inc | Anticuerpos anti factor d humanizados |
| RU2486253C2 (ru) | 2008-07-25 | 2013-06-27 | Инфоком Корпорейшн | Онкоген nrf2 и его применение |
| US20130330341A1 (en) * | 2011-02-23 | 2013-12-12 | Sanofi | Single nucleotide polymorphisms in the promoter of vegfa gene and their use as predictive markers for anti-vegf treatments |
| JO3283B1 (ar) | 2011-04-26 | 2018-09-16 | Sanofi Sa | تركيب يتضمن أفليبيرسيبت, حمض فولينيك, 5- فلورويوراسيل (5- Fu) وإرينوسيتان (FOLFIRI) |
| JP6040227B2 (ja) | 2011-05-19 | 2016-12-07 | アジーナ バイオサイエンス， インコーポレイテッド | マルチプレックス核酸同定のための製品およびプロセス |
| WO2013030032A1 (en) * | 2011-08-26 | 2013-03-07 | F. Hoffmann-La Roche Ag | A method for predicting clinical benefit in the treatment of neurodevelopmental, neurological or neuropsychiatric disorders |
| BR112014008862A2 (pt) * | 2011-10-14 | 2018-08-07 | Genentech Inc | anticorpo isolado que se liga à htra1, ácido nucleico isolado, célula hospedeira, imunoconjugado, formulação farmacêutica, métodos e usos |
| US20140004105A1 (en) * | 2012-06-29 | 2014-01-02 | Sequenom, Inc. | Age-related macular degeneration diagnostics |
| SG11201601044XA (en) | 2013-08-12 | 2016-03-30 | Genentech Inc | Compositions and method for treating complement-associated conditions |
| AU2015253042A1 (en) | 2014-05-01 | 2016-10-20 | Genentech, Inc. | Anti-factor D antibody variants and uses thereof |
| US9840553B2 (en) | 2014-06-28 | 2017-12-12 | Kodiak Sciences Inc. | Dual PDGF/VEGF antagonists |
| EA035674B1 (ru) | 2014-07-18 | 2020-07-24 | Санофи | Способ определения того, является ли пациент, предположительно страдающий от рака, кандидатом для терапии афлиберцептом |
| WO2016100745A2 (en) * | 2014-12-19 | 2016-06-23 | Children's Hospital Medical Center | Methods and compositions related to transplant-associated thrombotic microangiopathy |
| AU2016250841A1 (en) | 2015-04-24 | 2017-11-02 | Agena Bioscience, Inc. | Multiplexed method for the identification and quantitation of minor alleles and polymorphisms |
| CN104878105B (zh) * | 2015-06-02 | 2017-10-31 | 北京医院 | 一种预测雷珠单抗治疗年龄相关性黄斑变性疗效的试剂 |
| CN104894261B (zh) * | 2015-06-02 | 2020-02-14 | 北京医院 | 一种预测雷珠单抗治疗年龄相关性黄斑变性疗效的试剂盒 |
| US10407510B2 (en) | 2015-10-30 | 2019-09-10 | Genentech, Inc. | Anti-factor D antibodies and conjugates |
| EP3368090A1 (en) | 2015-10-30 | 2018-09-05 | H. Hoffnabb-La Roche Ag | Anti-factor d antibody variant conjugates and uses thereof |
| KR20250057128A (ko) | 2015-12-30 | 2025-04-28 | 코디악 사이언시스 인코포레이티드 | 항체 및 이의 접합체 |
| CN115951066A (zh) * | 2016-02-29 | 2023-04-11 | 麦恩泰科特有限公司 | 可用于治疗湿性年龄相关性黄斑变性的预测性标志物 |
| US10526315B2 (en) | 2016-06-21 | 2020-01-07 | Orion Ophthalmology LLC | Carbocyclic prolinamide derivatives |
| PL3472149T3 (pl) | 2016-06-21 | 2024-02-12 | Orion Ophthalmology LLC | Heterocykliczne pochodne prolinamidu |
| EP3758737A4 (en) | 2018-03-02 | 2022-10-12 | Kodiak Sciences Inc. | IL-6 ANTIBODIES AND FUSION CONSTRUCTS AND CONJUGATES THEREOF |
| CA3157509A1 (en) | 2019-10-10 | 2021-04-15 | Kodiak Sciences Inc. | Methods of treating an eye disorder |
| CN113373236B (zh) * | 2021-02-19 | 2021-12-31 | 中国科学院北京基因组研究所(国家生物信息中心) | 一种获得中国人群个体年龄的方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8311018D0 (en) | 1983-04-22 | 1983-05-25 | Amersham Int Plc | Detecting mutations in dna |
| US4998617A (en) | 1986-09-15 | 1991-03-12 | Laura Lupton Inc | Facial cosmetic liquid make up kit |
| US5202231A (en) | 1987-04-01 | 1993-04-13 | Drmanac Radoje T | Method of sequencing of genomes by hybridization of oligonucleotide probes |
| US6270961B1 (en) | 1987-04-01 | 2001-08-07 | Hyseq, Inc. | Methods and apparatus for DNA sequencing and DNA identification |
| US5176996A (en) | 1988-12-20 | 1993-01-05 | Baylor College Of Medicine | Method for making synthetic oligonucleotides which bind specifically to target sites on duplex DNA molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use |
| US5256775A (en) | 1989-06-05 | 1993-10-26 | Gilead Sciences, Inc. | Exonuclease-resistant oligonucleotides |
| FR2650840B1 (fr) | 1989-08-11 | 1991-11-29 | Bertin & Cie | Procede rapide de detection et/ou d'identification d'une seule base sur une sequence d'acide nucleique, et ses applications |
| US5264564A (en) | 1989-10-24 | 1993-11-23 | Gilead Sciences | Oligonucleotide analogs with novel linkages |
| US5210015A (en) | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| US6004744A (en) | 1991-03-05 | 1999-12-21 | Molecular Tool, Inc. | Method for determining nucleotide identity through extension of immobilized primer |
| US5858659A (en) | 1995-11-29 | 1999-01-12 | Affymetrix, Inc. | Polymorphism detection |
| US5952172A (en) | 1993-12-10 | 1999-09-14 | California Institute Of Technology | Nucleic acid mediated electron transfer |
| US5968740A (en) | 1995-07-24 | 1999-10-19 | Affymetrix, Inc. | Method of Identifying a Base in a Nucleic Acid |
| KR100816621B1 (ko) | 1997-04-07 | 2008-03-24 | 제넨테크, 인크. | 항-ｖｅｇｆ 항체 |
| WO1999013108A1 (en) | 1997-09-10 | 1999-03-18 | University Of Maryland, Baltimore | Method of amplifying dna and rna mismatch cleavage products |
| JP2008520242A (ja) * | 2004-11-18 | 2008-06-19 | イェール ユニバーシティ | 視覚障害を処置するための方法および組成物 |
| WO2008103299A2 (en) * | 2007-02-16 | 2008-08-28 | Massachusetts Eye & Ear Infirmary | Methods and compositions for prognosing, detecting, and treating age-related macular degeneration |
-
2009
- 2009-11-05 DK DK12185155.4T patent/DK2540843T3/da active
- 2009-11-05 US US13/127,433 patent/US20120003641A1/en not_active Abandoned
- 2009-11-05 ES ES12185155.4T patent/ES2498274T3/es active Active
- 2009-11-05 CN CN201310181349.5A patent/CN103333952B/zh not_active Expired - Fee Related
- 2009-11-05 MX MX2011004763A patent/MX2011004763A/es active IP Right Grant
- 2009-11-05 EP EP12185155.4A patent/EP2540843B1/en active Active
- 2009-11-05 JP JP2011534924A patent/JP5701216B2/ja not_active Expired - Fee Related
- 2009-11-05 WO PCT/US2009/063434 patent/WO2010054110A2/en not_active Ceased
- 2009-11-05 PL PL12185155T patent/PL2540843T3/pl unknown
- 2009-11-05 EP EP09748682A patent/EP2356250A2/en not_active Withdrawn
- 2009-11-05 AU AU2009313475A patent/AU2009313475B2/en not_active Ceased
- 2009-11-05 SI SI200931009T patent/SI2540843T1/sl unknown
- 2009-11-05 CN CN200980144066.5A patent/CN102203296B/zh not_active Expired - Fee Related
- 2009-11-05 CA CA2740242A patent/CA2740242A1/en not_active Abandoned
- 2009-11-05 KR KR1020117010284A patent/KR101719376B1/ko not_active Expired - Fee Related
-
2011
- 2011-03-29 IL IL211995A patent/IL211995A/en active IP Right Grant
-
2016
- 2016-07-20 US US15/215,426 patent/US20170159114A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012507988A5 (enExample) | ||
| RU2015101034A (ru) | Генетические полиморфизмы при возрастной дегенерации желтого пятна | |
| US20220206001A1 (en) | Methods and systems for detecting coronavirus | |
| JP2009541204A5 (enExample) | ||
| JP2020526478A5 (enExample) | ||
| JP2011528561A5 (enExample) | ||
| JP2007510664A5 (enExample) | ||
| RU2009120052A (ru) | Композиции и способы связывания сфингозин-1-фосфата | |
| JP2016516400A5 (enExample) | ||
| RU2015126533A (ru) | Анти-cd47 антитела и способы их применения | |
| CA2938731A1 (en) | Methods of treating alzheimer's disease | |
| JP2021501744A5 (enExample) | ||
| CN106536754A (zh) | 用il‑13拮抗剂选择性治疗哮喘的方法 | |
| JP2010533495A5 (enExample) | ||
| NZ602621A (en) | Antibodies against csf-1r | |
| JP2009518005A5 (enExample) | ||
| JP2009539348A5 (enExample) | ||
| JP2022525377A5 (enExample) | ||
| JP2020537520A5 (enExample) | ||
| RU2013153592A (ru) | Анти-mif антитела | |
| JP2011527899A5 (enExample) | ||
| JP2012514473A5 (enExample) | ||
| CN103201393A (zh) | 使用多基因计分预测向晚期老年性黄斑变性的进展 | |
| JP2018518151A5 (enExample) | ||
| JP2019534892A5 (enExample) |